61,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in über 4 Wochen
  • Broschiertes Buch

Code of Federal Regulations Title 21, Volume 1, April 1, 2016 contains regulations governing Food and Drugs and may also be referenced as: - Code of Federal Regulations Title 21, Volume 1, April 1, 2016 - CFR Title 21 - CFR 21, Food and Drugs - CFR 21, Parts 1 to 99, Food and Drugs This volume contains Parts 1 to 99: - Part 1; GENERAL ENFORCEMENT REGULATIONS - Part 2; GENERAL ADMINISTRATIVE RULINGS AND DECISIONS - Part 3; PRODUCT JURISDICTION - Part 4; REGULATION OF COMBINATION PRODUCTS - Part 5; ORGANIZATION - Part 7; ENFORCEMENT POLICY - Part 10; ADMINISTRATIVE PRACTICES AND PROCEDURES -…mehr

Produktbeschreibung
Code of Federal Regulations Title 21, Volume 1, April 1, 2016 contains regulations governing Food and Drugs and may also be referenced as: - Code of Federal Regulations Title 21, Volume 1, April 1, 2016 - CFR Title 21 - CFR 21, Food and Drugs - CFR 21, Parts 1 to 99, Food and Drugs This volume contains Parts 1 to 99: - Part 1; GENERAL ENFORCEMENT REGULATIONS - Part 2; GENERAL ADMINISTRATIVE RULINGS AND DECISIONS - Part 3; PRODUCT JURISDICTION - Part 4; REGULATION OF COMBINATION PRODUCTS - Part 5; ORGANIZATION - Part 7; ENFORCEMENT POLICY - Part 10; ADMINISTRATIVE PRACTICES AND PROCEDURES - Part 11; ELECTRONIC RECORDS; ELECTRONIC SIGNATURES - Part 12; FORMAL EVIDENTIARY PUBLIC HEARING - Part 13; PUBLIC HEARING BEFORE A PUBLIC BOARD OF INQUIRY - Part 14; PUBLIC HEARING BEFORE A PUBLIC ADVISORY COMMITTEE - Part 15; PUBLIC HEARING BEFORE THE COMMISSIONER - Part 16; REGULATORY HEARING BEFORE THE FOOD AND DRUG ADMINISTRATION - Part 17; CIVIL MONEY PENALTIES HEARINGS - Part 19; STANDARDS OF CONDUCT AND CONFLICTS OF INTEREST - Part 20; PUBLIC INFORMATION - Part 21; PROTECTION OF PRIVACY - Part 25; ENVIRONMENTAL IMPACT CONSIDERATIONS - Part 26; MUTUAL RECOGNITION OF PHARMACEUTICAL GOOD MANUFACTURING PRACTICE REPORTS, MEDICAL DEVICE QUALITY SYSTEM AUDIT REPORTS, AND CERTAIN MEDICAL DEVICE PRODUCT EVALUATION REPORTS: UNITED STATES AND THE EUROPEAN COMMUNITY - Part 50; PROTECTION OF HUMAN SUBJECTS - Part 54; FINANCIAL DISCLOSURE BY CLINICAL INVESTIGATORS - Part 56; INSTITUTIONAL REVIEW BOARDS - Part 58; GOOD LABORATORY PRACTICE FOR NONCLINICAL LABORATORY STUDIES - Part 60; PATENT TERM RESTORATION - Part 70; COLOR ADDITIVES - Part 71; COLOR ADDITIVE PETITIONS - Part 73; LISTING OF COLOR ADDITIVES EXEMPT FROM CERTIFICATION - Part 74; LISTING OF COLOR ADDITIVES SUBJECT TO CERTIFICATION - Part 80; COLOR ADDITIVE CERTIFICATION - Part 81; GENERAL SPECIFICATIONS AND GENERAL RESTRICTIONS FOR PROVISIONAL COLOR ADDITIVES FOR USE IN FOODS, DRUGS, AND COSMETICS - Part 82; LISTING OF CERTIFIED PROVISIONALLY LISTED COLORS AND SPECIFICATIONS - Parts 83-98; Reserved - Part 99; DISSEMINATION OF INFORMATION ON UNAPPROVED/NEW USES FOR MARKETED DRUGS, BIOLOGICS, AND DEVICES